Trial site
Velocity Nova Sp. z o.o.
- 16running trials
- 9closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes6 trials
- Atopic dermatitis (eczema)3 trials
- Obesity3 trials
- Heart failure2 trials
- Lupus (SLE)2 trials
- Ankylosing spondylitis1 trial
- Atrial fibrillation1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Insomnia1 trial
- and 5 more
- Phase
- Phase 321 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting9 trials
- Completed9 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Sanofi4 trials
- Ascletis Pharma (China) Co. Ltd.2 trials
- Boehringer Ingelheim2 trials
- Janssen Research & Development, LLC2 trials
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Active, not recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Obesity2 recruiting
- Type 2 diabetes2 recruiting
- Coronary artery disease1 recruiting
- Insomnia1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Recruiting
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Completed
Completed
A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis
Completed
Active, not recruiting
Completed
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Site data: ClinicalTrials.govUpdated 15 Nov 2026